Brought to you by 
Series E venture round brings in $24mm for Tryton Medical
15 Feb 2013
Executive Summary
Cardiovascular device firm Tryton Medical Inc. has raised $24mm through the initial tranche of its Series E venture round. All of its backers participated, including PTV Sciences (lead), RiverVest Venture Partners, Spray Venture Partners, and the 3x5 Special Opportunity Fund. The money will be used to get Tryton’s Side Branch Stent through US approval; submission is expected later this year. Additional funds will be used to support further development into the left main disease indication and to expand its products into Asia.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series E venture round brings in $24mm for Tryton Medical
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice